Standard BioTools Inc

NASDAQ: LAB
$2.15
-$0.03 (-1.4%)
Closing Price on November 8, 2024

LAB Stock Chart and Intraday Price

LAB Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 7000 SHORELINE COURT, SUITE 100, SOUTH SAN FRANCISCO, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 724.52M USD
Shares Outstanding 289,809,000
Standard BioTools Inc. is a global provider of innovative tools for the life sciences sector, focusing on research and clinical laboratories. The company designs and sells a broad range of products including analytical systems like Helios and Hyperion, assays, reagents, and software solutions aimed at advancing immuno-oncology, genotyping, and single-cell microfluidics. With a strong emphasis on technology and collaboration, Standard BioTools partners with leading institutions and companies to enhance scientific discovery and healthcare. Originally known as Fluidigm Corporation, it rebranded in 2022 and is based in South San Francisco, California.

LAB Articles

NFL Owner and Mexican Billionaire Are Back, Plus More Insider Buying
The owner of the Dallas Cowboys and Mexican billionaire Carlos Slim both continued to boost their stakes in energy stocks last week.
Trey Thoelcke
Published:

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
Trey Thoelcke
Published: